Skip to content

CorQuest MedTech

Active
Private limited companyfounded 20197 yrs activeRue Lieut.Col.Maniette(TX) 4, 5020 Namur, BelgiumKBO/BCE: BE 0733.537.853
Summary

CorQuest MedTech has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €552,771 and a net result of -€194,609. Equity is growing by ~28.8% per year across the filed fiscal years. Its solvency ranks better than 80% of 127 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
Axes · tick = 2024
Profitability0=
Solvency100=
Growth52=
Track record100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €30,000 at 30 days acceptable
Liquidity short (current ratio 0.37 against 0.9 in 2024; short-term debt: 18% and cash: 6.2% of total assets), and 18.1% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 26
Relative position
BE, all sectors
reference
Manufacture of computer, electronic and optical products (NACE 26)
about 73% fewer bankruptcies
← fewer bankruptcies more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 7 years 0 10 y
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
202122232425
2020 to 2025 · latest year -€194,609
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 24-08-2026, 24 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filings
Deviation from the deadline
2025
24 d late
2024
31 d late
2023
on the day
2022
32 d early
2021
9 d late
2020
66 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 16 days after the deadline; the sector median for financial year 2024 is 8 days before the deadline, and 34% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 9 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 30 August 2019, CorQuest MedTech was incorporated as a Private limited company.1 Total assets went from EUR 12,645 in 2020 to EUR 675,137 in 2025 and headcount from 0.3 full-time equivalents in 2022 to 1 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2020, 2022 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Turnover
Not included in this filing
EBIT margin
Not included in this filing
Net result
-€194,609▼ 20.0%
2024 · -€162,238
Working capital
-€76,283▼ 317%
2024 · -€18,280
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 26, Manufacture of computer, electronic and optical products, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€32,109▲ 77.7%€168,401-€17,440-€163,307▼ 836%-€193,765▼ 18.7%
Net result-€32,350below the sector's middle half▲ 77.5%€167,922within the sector's middle half-€17,876below the sector's middle half-€162,238below the sector's middle half▼ 808%-€194,609below the sector's middle half▼ 20.0%
Equity€324,572below the sector's middle half€492,494within the sector's middle half▲ 51.7%€474,618below the sector's middle half▼ 3.6%€747,380within the sector's middle half▲ 57.5%€552,771within the sector's middle half▼ 26.0%
Total assets€500,607below the sector's middle half▲ 3,859%€672,793below the sector's middle half▲ 34.4%€730,171below the sector's middle half▲ 8.5%€925,089below the sector's middle half▲ 26.7%€675,137within the sector's middle half▼ 27.0%
Debt€176,035▲ 13.0%€180,299▲ 2.4%€255,553▲ 41.7%€177,709▼ 30.5%€122,366▼ 31.1%
Working capital€324,919within the sector's middle half€270,874within the sector's middle half▼ 16.6%€26,534below the sector's middle half▼ 90.2%-€18,280below the sector's middle half-€76,283below the sector's middle half▼ 317%
Solvency64.8%within the sector's middle half73.2%above the sector's middle half▲ 8.4pp65.0%within the sector's middle half▼ 8.2pp80.8%above the sector's middle half▲ 15.8pp81.9%above the sector's middle half▲ 1.1pp
Current ratio2.85within the sector's middle half▲ 2.772.51within the sector's middle half▼ 0.341.10below the sector's middle half▼ 1.400.90below the sector's middle half▼ 0.210.37below the sector's middle half▼ 0.53
Return on assets (ROA)-6.5%below the sector's middle half25.0%above the sector's middle half▲ 31.4pp-2.4%below the sector's middle half▼ 27.4pp-17.5%below the sector's middle half▼ 15.1pp-28.8%below the sector's middle half▼ 11.3pp
Staff (FTE)0.3below the sector's middle half1below the sector's middle half▲ 233%1below the sector's middle half=1within the sector's middle half=
above within below the middle half (P25 to P75) of NACE 26, Manufacture of computer, electronic and optical products, each year against the same schema; no band under 30 filings.
Result per fiscal year
Operating resultNet result
-€200,000-€100,000€0€100,000€200,000Operating result 2021: -€32,109-€32,109Net result 2021: -€32,350-€32,350Operating result 2022: €168,401€168,401Net result 2022: €167,922€167,922Operating result 2023: -€17,440-€17,440Net result 2023: -€17,876-€17,876Operating result 2024: -€163,307-€163,307Net result 2024: -€162,238-€162,238Operating result 2025: -€193,765-€193,765Net result 2025: -€194,609-€194,60920212022202320242025-€200,000-€150,000-€100,000-€50,000€0Operating result 2023: -€17,440-€17,400Net result 2023: -€17,876-€17,900Operating result 2024: -€163,307-€163,000Net result 2024: -€162,238-€162,000Operating result 2025: -€193,765-€194,000Net result 2025: -€194,609-€195,000202320242025
The operating result stays negative: a loss of €193,765 in 2025 against €163,307 in 2024; the loss grows and 2025 has the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €675,137
Fixed assets €630,161 ▼ 17.8%
Current assets €44,976 ▼ 71.6%
Equity and liabilities €675,137
Equity €552,771 ▼ 26.0%
Debt €122,366 ▼ 31.1%
Debt's share of the balance-sheet total falls from 19.2% to 18.1%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
-€6,397▲
2024 · -€60,035
Cash flow
-€7,241▲
2024 · -€58,966
Debt to equity
0.22▼
2024 · 0.24
ROE
-35.2%▼
2024 · -21.7%
Interest coverage
-6.54▲
2024 · -54.59
Debt ≤ 1 year
€121,258▼
2024 · €176,592
Staff costs
€21,986▼
2024 · €90,368
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 3,597 companies that looked in July 2024 the way this one looks now, 2.8% went bankrupt within 24 months and 87% are still going.

  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a loss of 10% of the balance sheet or more
2.8% went bankrupt
9.2% stopped otherwise
87% still going

A further 0.8% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.4% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 3,597 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 37 lines
Balance sheet Code20242025
Assets
Total assets20/58€925,089€675,137▼
Fixed assets21/28€766,776€630,161▼
Intangible fixed assets21€766,776€630,161▼
Current assets29/58€158,312€44,976▼
Amounts receivable within one year40/41€49,270€2,439▼
Trade receivables40€38,814€359▼
Other amounts receivable41€10,456€2,079▼
Cash at bank and in hand54/58€108,463€41,792▼
Deferred charges and accrued income490/1€580€745▲
Equity and liabilities
Total equity and liabilities10/49€925,089€675,137▼
Equity10/15€747,380€552,771▼
Contributions10/11€936,000€936,000=
Profit (loss) carried forward14-€188,620-€383,229▼
Amounts payable17/49€177,709€122,366▼
Amounts payable within one year42/48€176,592€121,258▼
Trade debts44€48,576€5,960▼
Suppliers440/4€48,576€5,960▼
Taxes, remuneration and social security45€12,971-
Remuneration and social security454/9€12,971-
Other amounts payable47/48€115,045€115,298▲
Accrued charges and deferred income492/3€1,116€1,108▼
Income statement Code20242025
Remuneration, social security and pensions62€90,368€21,986▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€103,273€187,368▲
Other operating charges640/8€1,755€2,887▲
Gross operating margin9900€32,088€18,476▼
Operating profit (loss)9901-€163,307-€193,765▼
Financial income75/76B€2,924€135▼
Recurring financial income75€2,924€135▼
Financial charges65/66B€1,100€979▼
Recurring financial charges65€1,100€979▼
Profit (loss) for the period before taxes9903-€161,483-€194,609▼
Income taxes67/77€755-
Profit (loss) for the period9904-€162,238-€194,609▼
Profit (loss) for the period to be appropriated9905-€162,238-€194,609▼
Appropriation of the result
Profit (loss) to be appropriated9906-€188,620-€383,229▼
Profit (loss) brought forward from the previous period14P-€26,382-€188,620▼
Social balance
Average headcount (FTE)90871.01.0=

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62-€22,071€100,044€90,368€21,986▼ 75.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630-€18,743€48,229€103,273€187,368▲ 81.4%
Other operating charges640/8€601€2,423€747€1,755€2,887▲ 64.5%
Gross operating margin9900-€31,508€211,639€131,580€32,088€18,476▼ 42.4%
Operating profit (loss)9901-€32,109€168,401-€17,440-€163,307-€193,765▼ 18.7%
Financial income75/76B€1-€77€2,924€135▼ 95.4%
Recurring financial income75€1-€77€2,924€135▼ 95.4%
Financial charges65/66B€242€479€513€1,100€979▼ 11.0%
Recurring financial charges65€242€479€513€1,100€979▼ 11.0%
Profit (loss) for the period before taxes9903-€32,350€167,922-€17,876-€161,483-€194,609▼ 20.5%
Income taxes67/77---€755--
Profit (loss) for the period9904-€32,350€167,922-€17,876-€162,238-€194,609▼ 20.0%
Profit (loss) for the period to be appropriated9905-€32,350€167,922-€17,876-€162,238-€194,609▼ 20.0%
Line20212022202320242025Change
Assets
Total assets20/58€500,607€672,793€730,171€925,089€675,137▼ 27.0%
Fixed assets21/28-€221,968€448,817€766,776€630,161▼ 17.8%
Intangible fixed assets21-€221,968€448,817€766,776€630,161▼ 17.8%
Current assets29/58€500,607€450,825€281,355€158,312€44,976▼ 71.6%
Amounts receivable within one year40/41€119€47,526€13,003€49,270€2,439▼ 95.1%
Trade receivables40-€35,398-€38,814€359▼ 99.1%
Other amounts receivable41€119€12,128€13,003€10,456€2,079▼ 80.1%
Cash at bank and in hand54/58€500,488€403,299€267,748€108,463€41,792▼ 61.5%
Deferred charges and accrued income490/1--€604€580€745▲ 28.6%
Equity and liabilities
Total equity and liabilities10/49€500,607€672,793€730,171€925,089€675,137▼ 27.0%
Equity10/15€324,572€492,494€474,618€747,380€552,771▼ 26.0%
Contributions10/11€501,000€501,000€501,000€936,000€936,000=
Profit (loss) carried forward14-€176,428-€8,506-€26,382-€188,620-€383,229▼ 103%
Amounts payable17/49€176,035€180,299€255,553€177,709€122,366▼ 31.1%
Amounts payable within one year42/48€175,688€179,951€254,821€176,592€121,258▼ 31.3%
Trade debts44€58,328€60,054€109,220€48,576€5,960▼ 87.7%
Suppliers440/4€58,328€60,054€109,220€48,576€5,960▼ 87.7%
Taxes, remuneration and social security45-€2,531€28,236€12,971--
Taxes450/3-€1,638€3,463---
Remuneration and social security454/9-€893€24,773€12,971--
Other amounts payable47/48€117,360€117,366€117,366€115,045€115,298▲ 0.2%
Accrued charges and deferred income492/3€347€348€732€1,116€1,108▼ 0.8%
Line20212022202320242025Change
Profit (loss) for the period9904-€32,350€167,922-€17,876-€162,238-€194,609▼ 20.0%
+ Depreciation and write-downs630-€18,743€48,229€103,273€187,368▲ 81.4%
Operating cash flow (approximation)-€32,350€186,665€30,353-€58,966-€7,241▲ 87.7%
Investment in fixed assets (approximation)---€275,077-€421,232-€50,753▲ 88.0%
Change in cash--€97,189-€135,551-€159,285-€66,671▲ 58.1%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
24-08
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema · 24 days late
2025
31-12
Financial Weakest financial yearnet -€194,609
Net result drops to -€194,609, the lowest in the series.
31-08
NBB filing Annual accounts filed
fiscal year 2024 · full schema · 31 days late
2024
31-12
Financial Equity above €500,000Eq €747,380 ▲57.5%
Equity rises from €474,618 to €747,380.
31-07
NBB filing Annual accounts filed
fiscal year 2023 · full schema
2023
29-06
NBB filing Annual accounts filed
fiscal year 2022 · full schema
2022
31-12
Financial Back to profitnet €167,922
Net result €167,922 after 2 loss-making years.
09-08
NBB filing Annual accounts filed
fiscal year 2021 · full schema · 9 days late
2021
31-12
Financial Liquidity times 35current ratio 2.85
Current ratio from 0.08 to 2.85.
31-12
Financial Equity above €200,000Eq €324,572
Equity rises from -€143,078 to €324,572.
05-10
NBB filing Annual accounts filed
fiscal year 2020 · full schema · 66 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 6 acts read
About the unread acts

We know of 6 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Namur · 1 establishment unit since 2019
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Rue Lieut.Col.Maniette(TX) 45020 Namur
Ground area
4.0 ha
Building footprint
1.2 ha
Volume, LiDAR
100,446 m³
Parcel 25386B0152/00N000, Wallonia · tallest building 34.9 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
CorQuest MedTech
Chemin du Cyclotron 6, 1348 Ottignies-Louvain-la-NeuveScientific research and development
since 20192.292.932.025
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
25386B0152/00N000 Wallonia 4.0 ha 1 · 1.2 ha 34.9 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 48 companies in sector 26600 we hold annual accounts for 29. 20 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded30-08-2019
Fiscal year end31-12
Activities, NACEBEL 2025
26600Manufacture of computer, electronic and optical products
32500Manufacture of medical and dental instruments and supplies
46190Agents in non-specialised wholesale trade
46460Wholesale of pharmaceutical and medical goods
47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses
72101Research and development on biotechnology
72109Other research and development on natural sciences
74999Other professional, scientific and technical activities
77225Rental and leasing activities
82990Other business support services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0733537853
Also 9925:BE0733537853
Registered 24-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.